Literature DB >> 32340679

A Modified Algorithm Adjusting Both High and Minor Allele Frequency Mutation to Redefine Blood-Based Tumor Mutational Burden (bTMB) for Optimal Prediction of Clinical Benefits From Immune Checkpoint Inhibitor Therapy.

Zhichao Liu1, Zhanhong Xie1, Xiuyu Cai2, Jianxing He1, Wenhua Liang3.   

Abstract

Mesh：

Year:  2020        PMID： 32340679     DOI： 10.1016/j.jtho.2019.12.120

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  5 in total

Review 1.  Emerging Blood-Based Biomarkers for Predicting Immunotherapy Response in NSCLC.

Authors:  Ana Oitabén; Pablo Fonseca; María J Villanueva; Carme García-Benito; Aida López-López; Alberto Garrido-Fernández; Clara González-Ojea; Laura Juaneda-Magdalena; Martín E Lázaro; Mónica Martínez-Fernández
Journal:  Cancers (Basel)       Date:  2022-05-26       Impact factor: 6.575

Review 2.  Assessing tumor heterogeneity: integrating tissue and circulating tumor DNA (ctDNA) analysis in the era of immuno-oncology - blood TMB is not the same as tissue TMB.

Authors:  Stanislav Fridland; Jaeyoun Choi; Myungwoo Nam; Samuel Joseph Schellenberg; Eugene Kim; Grace Lee; Nathaniel Yoon; Young Kwang Chae
Journal:  J Immunother Cancer       Date:  2021-08       Impact factor: 13.751

Review 3.  The key to immunotherapy: how to choose better therapeutic biomarkers for patients with non-small cell lung cancer.

Authors:  Yue Pan; Yucheng Fu; Yue Zeng; Xiaohan Liu; Yurong Peng; Chunhong Hu; Chao Deng; Zhenhua Qiu; Jian Zou; Yuxuan Liu; Fang Wu
Journal:  Biomark Res       Date:  2022-03-07

4.  Predictive mutation signature of immunotherapy benefits in NSCLC based on machine learning algorithms.

Authors:  Zhichao Liu; Guo Lin; Zeping Yan; Linduo Li; Xingchen Wu; Jingrong Shi; Jianxing He; Lei Zhao; Hengrui Liang; Wei Wang
Journal:  Front Immunol       Date:  2022-09-27       Impact factor: 8.786

Review 5.  [Blood-based Biomarkers in the Immune Checkpoint Inhibitor Treatment in 
Non-small Cell Lung Cancer].

Authors:  Peng Wang; Chuanhao Tang; Jun Liang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2021-06-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.